Chlorosuccinimide → 3,5-Dichloro-7-(2,4-dichlorophenyl)imidazo[1,2-c]pyrimidine
Reaction equation
[Cl:1][C:2]1[N:7]2[CH:8]=[CH:9][N:10]=[C:6]2[CH:5]=[C:4]([C:11]2[CH:16]=[CH:15][C:14]([Cl:17])=[CH:13][C:12]=2[Cl:18])[N:3]=1.[Cl:19]N1C(=O)CCC1=O>C(Cl)(Cl)Cl.C(OCC)(=O)C.O>[Cl:19][C:8]1[N:7]2[C:2]([Cl:1])=[N:3][C:4]([C:11]3[CH:16]=[CH:15][C:14]([Cl:17])=[CH:13][C:12]=3[Cl:18])=[CH:5][C:6]2=[N:10][CH:9]=1Participants
6
Procedure
300 mg (1.0 mmol) of 5-chloro-7-(2,4-dichlorophenyl)imidazo[1,2-c]pyrimidine (Example 6A) are suspended in chloroform (15 ml), 240 mg (1.8 mmol) of N-chlorosuccinimide are added, and the reaction mixture is stirred at RT for 12 h. The reaction mixture is diluted with ethyl acetate (100 ml) and water (75 ml), and the organic phase is separated off, dried over magnesium sulphate and concentrated in a rotary evaporator. The residue is stirred with diethyl ether (20 ml), and the solid is filtered off with suction and dried. 63 mg (18% of theory) of the product are isolated.
Workup
- customthe organic phase is separated off
- dry with materialdried over magnesium sulphate
- concentrationconcentrated in a rotary evaporator
- stirringThe residue is stirred with diethyl ether (20 ml)
- filtrationthe solid is filtered off with suction
- customdried
- custom63 mg (18% of theory) of the product are isolated
Sources & evidence
- ORD record
- ord-adf832d58c8c4acf89e120fb387f936c
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08273752B2
Reaction notes
Loading…